“To Hold or Not to Hold? Periprocedural Management of Glucagon-Like Peptide-1 Receptor‑based Agonists (GLP‑1ra) in Patients With Diabetes and Obesity”. Canadian Diabetes & Endocrinology Today, vol. 4, no. 1, May 2026, pp. 26–34, https://doi.org/10.58931/cdet.2026.4152.